drugset / Trial / NCT00003935

Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

NCT00003935

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one drug with radiation therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of vincristine plus etoposide and radiation therapy in treating children who have newly diagnosed brain stem glioma.

Timeline

Start
1999-09
Primary completion
2003-10
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoposide Small molecule 50 mg/m2 Oral
Subject Vincristine Small molecule 1.5 mg/m2 Intravenous

Indications